Lemozy S, Pucilowska J B, Underwood L E
Department of Pediatrics, University of North Carolina School of Medicine, Chapel Hill 27599.
Endocrinology. 1994 Aug;135(2):617-23. doi: 10.1210/endo.135.2.7518385.
To investigate the influence of the insulin-like growth factor binding-proteins (IGFBPs) on the nutritional regulation of IGF-I's actions, we compared the gene expression of IGF-I and the six IGFBPs in liver and kidney of protein-restricted (P5) and normally fed (P15) young rats. Using poly(A)+ Northern blot analysis, we observed a decrease in IGF-I messenger RNA (mRNA) at steady state in liver (-50%) and kidney (-60%). The increases in IGFBP-1 mRNA were parallel in these two tissues (liver, 5.7-fold; kidney, 4-fold). In contrast, the expression of the other IGFBP genes exhibited organ-specific regulation during protein restriction; although IGFBP-2 mRNA increased in liver in the P5 group (3-fold), it decreased slightly in kidney (-15%). IGFBP-3 mRNA declined by 30% in liver and was unchanged in kidney. IGFBP-4 mRNA increased by 50-88% in liver and was not modified in kidney. IGFBP-5 mRNA was not detected in liver and was identical in kidney of P15 and P5 rats. IGFBP-6 mRNA was not changed in either liver or kidney during protein restriction. To determine whether the changes in IGFBP mRNAs induced by protein restriction were associated with changes in the respective peptides, IGFBPs in supernatants of liver homogenates and in serum of the same rats were measured by ligand blot analyses. IGFBP-1 and IGFBP-2 Western immunoblot analyses were also performed in serum. By ligand blot, a 45,000 mol wt (M(r)) band (IGFBP-3) decreased in liver and serum of P5 rats, paralleling the changes in liver IGFBP-3 mRNA. A 30,000 M(r) band, consistent with IGFBP-1 and/or IGFBP-2, increased in liver. By immunoblot in serum, IGFBP-1 was only detectable in P5 rats, whereas IGFBP-2 decreased in the P5 group. By ligand blot, a 24,000 M(r) band (IGFBP-4) declined slightly in serum (not detected in liver). Our study shows that protein restriction regulates the expression of four of six IGFBPs in rats, and this regulation is organ specific. The nutritional regulation of IGFBP peptides in biological fluids, in particular serum, seems to involve additional mechanisms.
为研究胰岛素样生长因子结合蛋白(IGFBPs)对IGF-I作用的营养调节的影响,我们比较了蛋白质限制(P5)和正常喂养(P15)的幼鼠肝脏和肾脏中IGF-I及六种IGFBP的基因表达。采用聚腺苷酸加尾(poly(A)+)Northern印迹分析,我们观察到肝脏(-50%)和肾脏(-60%)中稳态时IGF-I信使核糖核酸(mRNA)减少。IGFBP-1 mRNA在这两个组织中平行增加(肝脏,5.7倍;肾脏,4倍)。相比之下,在蛋白质限制期间,其他IGFBP基因的表达呈现器官特异性调节;尽管P5组肝脏中IGFBP-2 mRNA增加(3倍),但在肾脏中略有下降(-15%)。肝脏中IGFBP-3 mRNA下降30%,而肾脏中无变化。肝脏中IGFBP-4 mRNA增加50 - 88%,肾脏中未改变。P15和P5大鼠的肝脏中未检测到IGFBP-5 mRNA,肾脏中相同。蛋白质限制期间,肝脏和肾脏中的IGFBP-6 mRNA均未改变。为确定蛋白质限制诱导的IGFBP mRNA变化是否与相应肽段的变化相关,通过配体印迹分析测定了相同大鼠肝脏匀浆上清液和血清中的IGFBPs。还对血清进行了IGFBP-1和IGFBP-2 Western免疫印迹分析。通过配体印迹,P5大鼠肝脏和血清中一条45,000道尔顿分子量(M(r))的条带(IGFBP-3)减少,与肝脏中IGFBP-3 mRNA的变化平行。一条30,000 M(r)的条带,与IGFBP-1和/或IGFBP-2一致,在肝脏中增加。通过血清免疫印迹,仅在P5大鼠中可检测到IGFBP-1,而P5组中IGFBP-2减少。通过配体印迹,血清中一条24,000 M(r)的条带(IGFBP-4)略有下降(肝脏中未检测到)。我们的研究表明,蛋白质限制调节大鼠六种IGFBP中的四种的表达,且这种调节是器官特异性的。生物体液尤其是血清中IGFBP肽段的营养调节似乎涉及其他机制。